4-hydroxyglutethimide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 162086 |
| MeSH ID | M0065590 |
| Synonym |
|---|
| 3-ethyl-4-hydroxy-3-phenyl-2,6-piperidinedione |
| 4-hydroxytglutethimide |
| 2,6-piperidinedione, 3-ethyl-4-hydroxy-3-phenyl- |
| 4-hydroxyglutethimide |
| glutarimide, 2-ethyl-4-hydroxy-2-phenyl- |
| 50275-61-1 |
| k1t44q53sc , |
| unii-k1t44q53sc |
| JGIKUBAOSPIQHH-UHFFFAOYSA-N |
| glutarimide, 2-ethyl-4-hyroxy-2-phenyl- |
| 3-ethyl-4-hydroxy-3-phenyl-2,6-piperidinedione # |
| 3-hydroxy-2-ethyl-2-phenylglutarimide |
| 3-ethyl-4,6-dihydroxy-3-phenyl-4,5-dihydropyridin-2(3h)-one |
| DTXSID20964559 |
| Q27281831 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.72) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (20.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||